Brian A Markison - Net Worth and Insider Trading

Brian A Markison Net Worth

The estimated net worth of Brian A Markison is at least $9 Million dollars as of 2024-05-14. Brian A Markison is the Director of Immunomedics Inc and owns about 90,788 shares of Immunomedics Inc (IMMU) stock worth over $8 Million. Brian A Markison is the Director of Lantheus Holdings Inc and owns about 19,318 shares of Lantheus Holdings Inc (LNTH) stock worth over $2 Million. Brian A Markison is also the CEO of RVL Pharmaceuticals PLC and owns about 2,976,020 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $1,488. Details can be seen in Brian A Markison's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian A Markison has not made any transactions after 2023-03-27 and currently still holds the listed stock(s).

Transaction Summary of Brian A Markison

Brian A Markison Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian A Markison owns 7 companies in total, including Lantheus Holdings Inc (LNTH) , RVL Pharmaceuticals PLC (RVLPQ) , and Organogenesis Holdings Inc (ORGO) among others .

Click here to see the complete history of Brian A Markison’s form 4 insider trades.

Insider Ownership Summary of Brian A Markison

Ticker	Comapny	Transaction Date	Type of Owner
LNTH	Lantheus Holdings Inc	2023-03-27	director
RVLPQ	RVL Pharmaceuticals PLC	2022-08-08	director & Chief Executive Officer
ORGO	Organogenesis Holdings Inc	2018-08-17	director
		2017-11-20	director
		2017-10-03	director
		2011-09-22	director
		2017-10-03	director

Brian A Markison Latest Holdings Summary

Brian A Markison currently owns a total of 3 stocks. Among these stocks, Brian A Markison owns 90,788 shares of Immunomedics Inc (IMMU) as of November 20, 2017, with a value of $8 Million and a weighting of 84.07%. Brian A Markison owns 19,318 shares of Lantheus Holdings Inc (LNTH) as of March 27, 2023, with a value of $2 Million and a weighting of 15.92%. Brian A Markison also owns 2,976,020 shares of RVL Pharmaceuticals PLC (RVLPQ) as of August 8, 2022, with a value of $1,488 and a weighting of 0.02%.

Latest Holdings of Brian A Markison

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
IMMU	Immunomedics Inc	2017-11-20	90,788	87.86	7,976,634
LNTH	Lantheus Holdings Inc	2023-03-27	19,318	78.19	1,510,474
RVLPQ	RVL Pharmaceuticals PLC	2022-08-08	2,976,020	0.00	1,488

Holding Weightings of Brian A Markison

Brian A Markison Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian A Markison has made a total of 0 transactions in Immunomedics Inc (IMMU) over the past 5 years. The most-recent trade in Immunomedics Inc is the sale of 8,390 shares on November 20, 2017, which brought Brian A Markison around $99,757.

According to the SEC Form 4 filings, Brian A Markison has made a total of 11 transactions in Lantheus Holdings Inc (LNTH) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Lantheus Holdings Inc is the sale of 13,290 shares on March 27, 2023, which brought Brian A Markison around $1 Million.

According to the SEC Form 4 filings, Brian A Markison has made a total of 1 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RVL Pharmaceuticals PLC is the acquisition of 850,000 shares on August 8, 2022, which cost Brian A Markison around $1 Million.

Insider Trading History of Brian A Markison

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian A Markison Trading Performance

GuruFocus tracks the stock performance after each of Brian A Markison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian A Markison is 3.14%. GuruFocus also compares Brian A Markison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian A Markison within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian A Markison's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian A Markison

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	64.15
Relative Return to S&P 500(%)	67.38

Brian A Markison Ownership Network

Ownership Network List of Brian A Markison

No Data

Ownership Network Relation of Brian A Markison

Brian A Markison Owned Company Details

What does Lantheus Holdings Inc do?

Who are the key executives at Lantheus Holdings Inc?

Brian A Markison is the director of Lantheus Holdings Inc. Other key executives at Lantheus Holdings Inc include Chief Accounting Officer Andrea Sabens , CFO and Treasurer Marshall Robert J. Jr. , and Chief Commercial Officer Paul Blanchfield .

Lantheus Holdings Inc (LNTH) Insider Trades Summary

Over the past 18 months, Brian A Markison made 1 insider transaction in Lantheus Holdings Inc (LNTH) with a net sale of 13,290. Other recent insider transactions involving Lantheus Holdings Inc (LNTH) include a net sale of 14,813 shares made by Andrea Sabens , a net sale of 309,869 shares made by Mary Anne Heino , and a net sale of 85,441 shares made by Marshall Robert J. Jr. .

In summary, during the past 3 months, insiders sold 159,047 shares of Lantheus Holdings Inc (LNTH) in total and bought 0 shares, with a net sale of 159,047 shares. During the past 18 months, 551,711 shares of Lantheus Holdings Inc (LNTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,711 shares.

Lantheus Holdings Inc (LNTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lantheus Holdings Inc Insider Transactions

No Available Data

What does RVL Pharmaceuticals PLC do?

Who are the key executives at RVL Pharmaceuticals PLC?

Brian A Markison is the director & Chief Executive Officer of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .

RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary

Over the past 18 months, Brian A Markison made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Altchem Ltd , and a net sale of 17,544,196 shares made by Foundation Harsaul .

In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.

RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

RVL Pharmaceuticals PLC Insider Transactions

No Available Data

What does Organogenesis Holdings Inc do?

Who are the key executives at Organogenesis Holdings Inc?

Brian A Markison is the director of Organogenesis Holdings Inc. Other key executives at Organogenesis Holdings Inc include 10 percent owner Albert Erani , 10 percent owner Michael W Katz , and director & President and CEO Gary S. Gillheeney .

Organogenesis Holdings Inc (ORGO) Insider Trades Summary

Over the past 18 months, Brian A Markison made no insider transaction in Organogenesis Holdings Inc (ORGO). Other recent insider transactions involving Organogenesis Holdings Inc (ORGO) include a net sale of 481,786 shares made by Albert Erani , and a net purchase of 6,000 shares made by Michael W Katz .

In summary, during the past 3 months, insiders sold 0 shares of Organogenesis Holdings Inc (ORGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,786 shares of Organogenesis Holdings Inc (ORGO) were sold and 6,000 shares were bought by its insiders, resulting in a net sale of 475,786 shares.

Organogenesis Holdings Inc (ORGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Organogenesis Holdings Inc Insider Transactions

No Available Data

What does Immunomedics Inc do?

Who are the key executives at Immunomedics Inc?

Brian A Markison is the director of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .

Immunomedics Inc (IMMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunomedics Inc Insider Transactions

No Available Data

What does Alere Inc do?

Who are the key executives at Alere Inc?

Brian A Markison is the director of Alere Inc. Other key executives at Alere Inc include director & Chief Executive Officer Namal Nawana , Senior VP & Global R&D Renuka Uppaluri , and Senior VP & Global Operations Mark Gladwell .

Alere Inc (ALR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alere Inc (ALR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alere Inc (ALR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alere Inc (ALR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alere Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Brian A Markison is the director of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Brian A Markison made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Matthew Scott Harris .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

What does Alere Inc do?

Who are the key executives at Alere Inc?

Alere Inc (ALRPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alere Inc (ALRPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alere Inc (ALRPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alere Inc (ALRPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alere Inc Insider Transactions

No Available Data

Brian A Markison Mailing Address

Above is the net worth, insider trading, and ownership report for Brian A Markison. You might contact Brian A Markison via mailing address: 501 Fifth Street, Bristol Tn 37620.

Discussions on Brian A Markison

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.